Menu
Technology Transfer

Our Technology Transfer team works with Imperial College London academics and students.

We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisations, leading ultimately to licensing to industry partners, or the creation of new ventures.

Find out more
Ventures

Our ventures team creates, nurtures and invests in new technology ventures based on IP

We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.

Find out more

Imperial Innovations news

Portfolio overview

We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2014, the value of the top 30 investments in our portfolio stood at £226.1 million.

Portfolio subsectors

  • Therapeutics
  • Medtech
  • Engineering/Materials
  • ICT/Digital
£226.1m Total

Sector
Therapeutics
Investment amount
£25.5m
Investment stage
Listed

Overview

A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies



Sector
Engineering & Materials
Investment amount
£22.4m
Investment stage
post-Series A

Overview

Unique silicon anodes for next generation Lithium-ion batteries with improved energy density and cycle life



Sector
Medtech
Investment amount
£9.8m
Investment stage
post-Series A

Overview

3D stent technology intended to improve the biomechanical and blood flow characteristics of vascular stents



Sector
Therapeutics
Investment amount
£10.5m
Investment stage
post-Series A

Overview

Services and technologies to enable the development of better biopharmaceuticals


Investment details

Share price: 462.38p

IVO share price chart

Key information

Sector: Financial Services
Activities: Technology commercialisation, incubation and investment
EPIC: IVO
Status: AIM
Year end: 31 July